Media enquiries
Thank you for your message!
We will examine it with utmost attention and get back to you shortly.
Do you have
any question?
St-Cloud and Boulogne-Billancourt, France – November 10, 2020 – Ethypharm and Laboratoires CTRS announced today that they have entered into an exclusive agreement for the registration and commercialisation in the People’s Republic of China of the orphan medicine Orphacol® indicated for the treatment of patients with rare inborn errors in primary bile acid synthesis.
Thank you for your message!
We will examine it with utmost attention and get back to you shortly.